Last reviewed · How we verify

NCT03178877: IBS

The Prevalence of Irritable Bowel Syndrome Using Rome IV Criteria in Medical Student and The Related Factors

Completed Last updated 7 June 2017
What this trial tests

trial testing No intervention in IBS - Irritable Bowel Syndrome in 350 participants. Completed in 31 December 2016.

Timeline
1 November 2016
Primary endpoint
31 December 2016
31 December 2016

Quick facts

Lead sponsorIndonesia University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment350
Start date1 November 2016
Primary completion31 December 2016
Estimated completion31 December 2016
Sites1 location across Indonesia

Drugs / interventions tested

Conditions studied

Sponsor

Indonesia University

Who can join

Adults 15 to 30, any sex, with IBS - Irritable Bowel Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A cross-sectional study of 350 medical student Universitas Indonesia from first grade until fifth grade was done during November-December 2016. This study used stratified randomized sampling. The Rome IV criteria was used for diagnosing IBS. Questionnaire-guided interview was applied to all subjects.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

Other recruiting trials for IBS - Irritable Bowel Syndrome

Currently open trials in the same condition.

Other Indonesia University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03178877.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing